📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
10
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CCS.
💹 Market Data
Market Cap$1.54B
Shares Outstanding28.77M
Float24.77M
Cash$78.18M
Debt$1.54B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 9.4% shares (2025Q4 vs prior)
262 institutional holders · 27.00M shares
#1
BlackRock, Inc.
5.23M shares
#2
VANGUARD GROUP INC
1.98M shares
#3
DIMENSIONAL FUND ADVISORS LP
1.97M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.84M
Days to Cover6.5
% of Float7.4%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2013
4
INSIDER TRANSACTION
Mar 12, 2026
4
INSIDER TRANSACTION
Feb 13, 2026
4
INSIDER TRANSACTION
Feb 10, 2026
4
INSIDER TRANSACTION
Feb 06, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CCS
📊 CCS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CCS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.